Overview

Low-dose Buprenorphine Initiation of Opioid Use Disorder

Status:
Not yet recruiting
Trial end date:
2027-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether low-dose buprenorphine initiation for treatment of opioid use disorder is safe and effective.
Phase:
Phase 4
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Buprenorphine
Buprenorphine, Naloxone Drug Combination
Naloxone